Andrew Joseph Follow

Every article

1. Thursday, October 1, 2026

2. 06:16health
   STAT+: Sanofi, Regeneron expand partnership after Dupixent success STAT by Andrew Joseph story

3. Monday, September 21, 2026

4. 13:31health
   STAT+: Pharmalittle: We’re reading about Novo plans to expand its pipeline, early Alkermes ADHD data, and more STAT by Andrew Joseph story
5. 09:33health
   STAT+: With new strategy, Novo outlines plans for obesity, direct-to-consumer work STAT by Andrew Joseph story

6. Thursday, September 17, 2026

7. 18:00health
   STAT+: Why do ‘never smokers’ get lung cancer? In some cases, rare genetic variant may be a factor STAT by Andrew Joseph story
8. 11:59health
   STAT+: Pharmalittle: We’re reading about FDA hiring delays, a new Bavarian Nordic CEO, and more STAT by Andrew Joseph story
9. 07:42health
   STAT+: England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal STAT by Andrew Joseph story

10. Monday, September 14, 2026

11. 08:58health
    STAT+: What’s in a name? Novo looks to a rebrand STAT by Andrew Joseph story

12. Saturday, September 12, 2026

13. 07:09health
    STAT+: Breast cancer pill from AstraZeneca misses mark in pivotal trial STAT by Andrew Joseph story

14. Wednesday, September 9, 2026

15. 23:01health
    STAT+: U.K. unveils recommendations for regulating AI in medicine STAT by Andrew Joseph story

16. Monday, September 7, 2026

17. 11:13health
    STAT+: Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation STAT by Andrew Joseph

18. Tuesday, September 8, 2026

19. 07:28health
    STAT+: Neuromuscular drug from Novartis fails in key study, adding to pressure on company STAT by Andrew Joseph story
20. 11:45health
    STAT+: AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies STAT by Andrew Joseph story